Regenerative med biotech Satellite unveils tissue-based tech to restore organ function April 20, 2022 Auto Bot BioPharma, Cambridge, deals, investing, liver disease, Massachusetts, Pharma, regenerative medicine, Startups 0 Satellite Bio has emerged from stealth with technology for bioengineering tissue to restore organ function. The regenerative medicine startup, based on research from MIT and Boston University, is backed by $110 million in financing.